ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134 | -20.2% | 20,020 | 0.0% | 0.01% | -18.8% |
| Q2 2023 | $168 | -15.6% | 20,020 | 0.0% | 0.02% | -20.0% |
| Q1 2023 | $199 | +43.2% | 20,020 | 0.0% | 0.02% | +42.9% |
| Q4 2022 | $139 | -99.9% | 20,020 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $107,000 | +33.8% | 20,020 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $80,000 | -10.1% | 20,020 | 0.0% | 0.01% | +12.5% |
| Q1 2022 | $89,000 | +11.2% | 20,020 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $80,000 | -54.5% | 20,020 | 0.0% | 0.01% | -61.1% |
| Q3 2021 | $176,000 | -22.5% | 20,020 | 0.0% | 0.02% | -18.2% |
| Q2 2021 | $227,000 | -4.6% | 20,020 | 0.0% | 0.02% | -12.0% |
| Q1 2021 | $238,000 | +73.7% | 20,020 | 0.0% | 0.02% | +66.7% |
| Q4 2020 | $137,000 | -7.4% | 20,020 | 0.0% | 0.02% | -21.1% |
| Q3 2020 | $148,000 | -11.4% | 20,020 | -50.0% | 0.02% | -17.4% |
| Q2 2020 | $167,000 | +12.8% | 40,020 | -33.3% | 0.02% | +9.5% |
| Q1 2020 | $148,000 | -68.2% | 60,020 | -25.0% | 0.02% | -56.2% |
| Q4 2019 | $465,000 | +10.2% | 80,020 | 0.0% | 0.05% | +4.3% |
| Q3 2019 | $422,000 | +58.1% | 80,020 | +79.7% | 0.05% | +58.6% |
| Q2 2019 | $267,000 | -33.6% | 44,520 | 0.0% | 0.03% | -31.0% |
| Q1 2019 | $402,000 | -19.6% | 44,520 | -26.0% | 0.04% | -25.0% |
| Q4 2018 | $500,000 | -66.4% | 60,190 | -44.2% | 0.06% | -62.9% |
| Q3 2018 | $1,488,000 | +73.6% | 107,858 | 0.0% | 0.15% | +60.6% |
| Q2 2018 | $857,000 | +5.9% | 107,858 | 0.0% | 0.09% | -1.1% |
| Q1 2018 | $809,000 | +10.4% | 107,858 | 0.0% | 0.10% | +9.2% |
| Q4 2017 | $733,000 | -5.7% | 107,858 | 0.0% | 0.09% | -13.0% |
| Q3 2017 | $777,000 | +53.3% | 107,858 | 0.0% | 0.10% | +47.1% |
| Q2 2017 | $507,000 | +169.7% | 107,858 | +186.4% | 0.07% | +151.9% |
| Q1 2017 | $188,000 | – | 37,662 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |